348 European companies earn more than 20% of their revenues from the U.S. & Canada. Together, they generated over €1.5 trillion in 2024 sales to North America.
These companies are part of a wider universe of 1,652 listed firms in Europe (with market cap > €0.5bn). Of those, 610 disclose sales to the U.S. & Canada - and the 348 above are the ones with true dependency.
Who drives this?
At the very center: Roche, Novo Nordisk, AstraZeneca, Sanofi, Novartis.
About the chart
This heatmap shows the 348 European companies with more than 20% of sales to the U.S. & Canada
Europe is tied to the U.S. for €1.5 trillion in sales. In your portfolio, is that a strength - or a risk you need to hedge?